Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Cathie Wood Loads Up on Pinterest After 20% Plunge; ARK Adds CRISPR, Trims Roku, Robinhood & Teradyne (Nov 6, 2025)

Cathie Wood Loads Up on Pinterest After 20% Plunge; ARK Adds CRISPR, Trims Roku, Robinhood & Teradyne (Nov 6, 2025)

ARK’s Wednesday trade disclosure shows the firm bought 521,867 shares of Pinterest across three funds after the visual discovery platform cratered on guidance. The add looks like a classic Cathie Wood “buy the dip” move: step into high‑conviction names when volatility runs hottest. Investing.com+1
6 November 2025
········
Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Schwab will acquire all of Forge’s issued and outstanding common shares for $45 in cash per share. The companies expect to close in the first half of 2026, subject to customary approvals. Forge’s two largest shareholders—Motive Capital and Deutsche Börse—have signed support agreements backing the transaction. Business Wire
6 November 2025
···
Solid Power (SLDP) Charges Ahead: Will Solid-State Batteries Supercharge Its Stock?

Solid Power (SLDP) Charges Ahead: Will Solid-State Batteries Supercharge Its Stock?

Solid Power is an industry-leading developer of all-solid-state battery cells with a mission to “power the next generation of electric vehicles” via safer, high-performance energy storagedcfmodeling.comdcfmodeling.com. The company spun out of research at the University of Colorado and was founded in 2011 by a team of battery scientists and engineersdcfmodeling.com. After years of lab development and prototyping, Solid Power gained validation through partnerships with BMW and Ford, and it raised significant venture fundingdcfmodeling.com.
5 November 2025
··
Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Perrigo Company plc is a consumer healthcare and self-care products company with over a century of history in the OTC medicine space Perrigo. Now domiciled in Dublin, Ireland, Perrigo’s business spans a broad range of non-prescription health products. The company produces store-brand OTC medicines as well as its own branded products in categories like cough & cold remedies, pain relief, digestive health, vitamins, infant formula, and dermatology care Patsnap Patsnap. Perrigo’s unique business model leverages its cash-generating store-brand portfolio to fund the growth of its branded offerings – which include names like Opill®, Mederma® skincare, and allergy treatments like Nasonex Perrigo Patsnap.
5 November 2025
·
Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

As of November 5, 2025, Teradata’s stock trades in the mid-$20s after a sharp post-earnings rally. The latest trade was around $24.64, up ~19% in a single session Reuters. This big jump followed the company’s Q3 earnings announcement and reflects renewed investor confidence. Prior to the earnings, TDC was hovering near $20, meaning the stock has swiftly regained lost ground.
5 November 2025
···
Supreme Court Tariff Showdown: Trump’s Trillion-Dollar Trade Gamble Meets Skeptical Justices

Supreme Court Tariff Showdown: Trump’s Trillion-Dollar Trade Gamble Meets Skeptical Justices

In sum, the Supreme Court appears poised to make a definitive ruling on Trump’s tariff gambit – one that will either vindicate his bold use of emergency power or slam the brakes on it. The stakes are enormous: billions of dollars, the balance of economic power between Congress and the President, and the future course of U.S. trade policy all hang in the balance. As Hofstra law professor James Sample noted, this is “a staggeringly important case” that could reshape the economy and constitutional order for years to comeabcnews.go.com. Both Wall Street and Main Street await the outcome, bracing for a ruling that could reverberate from the factory floor to global markets. Whatever the justices decide, the aftermath will be a defining moment for how America makes its trade rules – through the President’s pen or by act of Congress – in the turbulent era of tariff wars and economic nationalism.
5 November 2025
SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Technologies’ stock has been on a tear in 2025, dramatically outperforming the broader market. As of November 5, 2025, SOFI trades around $29–30 per share, not far from its all-time high set just days earliertradingview.com. In late October, the stock spiked to an intraday record of $32.57247wallst.com, buoyed by optimism around its earnings. Even after pulling back about 7% from the peak in early November247wallst.com, SoFi shares are still up roughly 91% year-to-date and +171% versus a year agotradingview.com – a meteoric rise that has put the fintech firmly in the spotlight.
5 November 2025
··
Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer Inc. is one of the world’s largest pharmaceutical companies, known for household-name drugs and vaccines. Headquartered in New York, Pfizer manufactures treatments across vaccines, oncology, immunology, cardiology, and more. The company gained global prominence for its COVID-19 vaccine and antiviral pill. However, with the pandemic’s tide receding, Pfizer’s stock has faced significant challenges in 2023–2025. Shares that once traded above $50 during the vaccine rollout now hover in the mid-$20sreuters.com. At around $24–$25 per share, Pfizer’s market cap is about $138 billionstockanalysis.com – substantially smaller than several years ago and dwarfed by newer pharma stars.
5 November 2025
··
Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining’s stock has been on a tear. In the final week of October into early November 2025, CIFR rocketed from the high teens to the mid-$20s per sharestockanalysis.comstockanalysis.com. On Monday, Nov 3, shares opened slightly down but closed up over 22% in a single session247wallst.com – an eye-popping move for a mid-cap stock. This surge was directly catalyzed by the company’s Q3 earnings release and strategic partnership news. By mid-day Nov 5, CIFR was trading around $25stockanalysis.com, marking roughly a 35% gain week-to-date and a new 52-week high for the stock.
5 November 2025
··
Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Rubico Inc. is a Marshall Islands-incorporated shipping company providing crude oil transportation services via a small fleet of tankersglobenewswire.comglobenewswire.com. The company was created as a spin-off from TOP Ships Inc., a Greek tanker owner, to separately house two Suezmax oil tankersstocktwits.com. Both 2021-built vessels are “eco” fuel-efficient tankers on long-term time charter contracts with Clearlake, ensuring stable charter revenue streamsrivieramm.com. Rubico’s strategy focuses on owning and operating these modern tankers, leveraging their high specification and scrubber-fitted fuel efficiency to attract charterersglobenewswire.com.
5 November 2025
·
First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

First Majestic’s stock has had a rollercoaster year, skyrocketing through 2025 alongside the price of silver. The share price climbed from the ~$5 level in January to a 52-week high of $15.69 by late Octoberreuters.com, vastly outperforming broader mining indices. This 158% year-to-date surge was propelled by optimism around the Los Gatos acquisition and leverage to silver’s historic rallyinvesting.com.
5 November 2025
·
Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel’s stock has been on a tear in 2025, reflecting its improving fundamentals. As of November 5, 2025, RIGL trades around $38/share, up over 30% in a single day after its blowout Q3 earnings reportstockanalysis.com. The post-earnings volatility has been extreme – initially, shares fell ~7–8% in after-hours trading on Nov. 4 despite the strong results, possibly due to profit-taking or tempered forward outlook, dipping to about $30.32investing.com. However, sentiment swiftly reversed: by the next trading session, buyers piled in, and Rigel stock skyrocketed to new multi-month highs. The stock is now only a few points shy of its 52-week peak of $43.72investing.com.
5 November 2025
··
Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum made headlines on November 4–5, 2025 with a stellar earnings report that ignited its stock. The firm announced Q1 FY2026 results featuring record-high sales of $533.8 million – about 58% higher than a year agosimplywall.st and even slightly above Wall Street’s consensusmarketscreener.com. This top-line feat, the largest quarterly revenue in Lumentum’s 10-year historyoptics.org, was driven by unprecedented demand from AI and cloud networking customers. CEO Michael Hurlston highlighted that “over 60% of our total company revenue now comes from cloud and AI infrastructure” as hyperscalers deploy Lumentum’s optical components in data centersoptics.org. The AI-fueled sales boom helped Lumentum swing from a large loss last year to a modest profit this quarter – GAAP net income of $5M pre-tax, versus a nearly $80M loss in the year-ago periodoptics.org.
5 November 2025
··
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense & Security Solutions, Inc. is a U.S. technology company serving the defense and national security market. Founded in 1994 and headquartered in San Diego, Kratos specializes in mission-critical systems for military and government agenciesinvesting.com. The company operates through two main segments – Kratos Government Solutions and Unmanned Systems – offering a wide array of products and services. These include satellite ground communication systems, jet-powered unmanned aerial vehicles, missile and radar system solutions, advanced propulsion systems for missiles/spacecraft, cyber security and training platforms, and other military electronicsinvesting.com. Kratos’ primary customers are U.S. Department of Defense agencies, allied governments, and commercial entities with national security needsinvesting.com. The company is known for innovative, cost-effective defense solutions in high-growth areas like drones and space communicationstipranks.com, often positioning itself as a nimble alternative to traditional large defense contractors.
5 November 2025
···
Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox Enterprises, Inc. is an American energy technology and services provider with a 158-year legacy. Headquartered in Akron, Ohio, the company is historically renowned for its steam boilers used in power generation Wikipedia. Today, B&W’s offerings span advanced energy and environmental solutions for industrial and utility markets worldwide Tipranks. It engineers and supplies equipment for power generation, emissions control systems, and related services/parts.
5 November 2025
·····
Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex stock has endured a steep slide in 2025, culminating in a dramatic plunge after its early November earnings announcement. On November 5, 2025, TREX opened around $34–35 per share – down roughly 26% from the prior day’s close Streetinsider. This selloff pushed the stock to fresh 52-week lows, shattering the previous low of ~$46 Finviz. Prior to the earnings drop, Trex had already been trending downward for months; with this latest collapse, shares have lost about 50% of their value year-to-date Finviz and over 50% from 12-month highs.
5 November 2025
···
From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company pioneering an unusual dual focus: AI-driven drug discovery and biodefense. The company’s mission is to “capture biological signals at scale, decode them with AI, and rapidly validate insights in model systems”, bridging cutting-edge computation with experimental biotechainvest.comainvest.com. In practical terms, Lunai is developing both therapeutic platforms and advanced diagnostics/screening tools, all underpinned by machine learning.
5 November 2025
···
Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven’s recent troubles center on VYGLXIA – its lead drug candidate for spinocerebellar ataxia, a degenerative brain disorder that currently has no approved treatmentreuters.com. On November 4, 2025, after market close, Biohaven announced that the FDA had issued a Complete Response Letter rejecting the company’s New Drug Application. This CRL cited multiple concerns with Biohaven’s data: potential bias, design limitations, lack of pre-specification, and unmeasured confounding factors in the supporting studiesstocktwits.comstocktwits.com. In simpler terms, the FDA was uneasy with how Biohaven ran and analyzed its trials – particularly its use of real-world evidence and an external control group instead of a standard placebo-controlled trialreuters.com.
5 November 2025
·
Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Zeta Global made headlines on November 4, 2025 by reporting stellar third-quarter results and raising its guidance for the 17th straight quarterinvestors.zetaglobal.com. The Q3 earnings release showed better-than-expected revenue and profits, prompting a surge of optimism from investors and analysts alike. By the next day, ZETA’s stock price had soared roughly 15% in heavy trading as the market digested the newsstockanalysis.com. This marked a sharp positive turnaround, especially considering that just a few months prior the stock was languishing near yearly lows.
5 November 2025
···
1 … 66 67 68 69 70 … 164

Stock Market Today

  • IVP Limited (NSE:IVP) Nears Ex-Dividend Date as Dividend Remains Sustainable
    July 25, 2026, 11:33 PM EDT. Shares of IVP Limited (NSE:IVP) will go ex-dividend in 3 days, with a dividend of ₹1.50 per share slated for payment on September 5. The current trailing yield is approximately 1.0% based on the stock price of ₹151.02. IVP's dividend payout remains sustainable, with only 8.3% of profit after tax and 2.1% of free cash flow distributed. Five-year annual earnings growth averaging 33% underpins ongoing dividend stability and growth prospects.